Intelligence · Clinical pipeline
Phase II Pipeline Programs
Proof-of-concept and dose-finding clinical programs in Phase II development.
Quick answer
NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.
Top sponsors
- Chinese Academy of 432 programs
- BRIGHT MINDS BIOSCIENCES 393 programs
- First People's Hospital 375 programs
- United Therapeutics Europe 336 programs
- Takeda 335 programs
- Anaxis Pharma 223 programs
- George Institute for 187 programs
- Regeneron UK 176 programs
- Teva Pharma 126 programs
- Novartis India 121 programs
- Telethon Foundation 119 programs
- Disc Medicine 106 programs
Pipeline programs
-
Immune Globulin Intravenous (IVIG)
BRIGHT MINDS BIOSCIENCES INC.
Sickle Cell Disease
1 trial -
Immunization with P. vivax irradiated sporozoites
BRIGHT MINDS BIOSCIENCES INC.
Malaria
1 trial -
Immunological Agent
The First People's Hospital of Lianyungang
Lung Cancer Metastatic
1 trial -
Immunomodulatory DC vaccines to target prostate cancer
Shenzhen Second People's Hospital
Prostate Cancer Indications
1 trial -
Immunotherapy combined with chemotherapy
The First People's Hospital of Lianyungang
Rectal Adenocarcinoma
1 trial -
Impedance Threshold Device
United Therapeutics Europe Ltd
Hypotension
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Ichthyosis
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Acneiform Eruptions
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Acne Vulgaris
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Palmoplantar Pustulosis
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Hidradenitis Suppurativa
1 trial -
Imx-110
Immix Biopharma
Solid Tumor, Adult
1 trial -
Inactivated Poliomyelitis vaccine (IMOVAX)
Sanofi Pasteur
Poliomyelitis
1 trial -
Inactive Marijuana (0% THC)
BRIGHT MINDS BIOSCIENCES INC.
Marijuana Smoking
1 trial -
Inaxaplin
Vertex Pharmaceuticals (Australia) Pty.
Proteinuric Kidney Disease
1 trial -
Indapamide
Alnylam Netherlands B.V.
Hypertension
1 trial -
Indibulin
Alaunos Therapeutics
Metastatic Breast Cancer
1 trial -
Indigo naturalis ointment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis
1 trial -
Induction Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli,SBLPN
1 trial -
Induction of neo-antigen specific T cells by... for Ovarian cancer
Disc Medicine
Ovarian cancer
1 trial -
Induction therapy of GP(Pomalidomide+Obinutuzumab)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indolent Lymphoma
1 trial -
Inetetamab
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Achondroplasia
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Hypochondroplasia
1 trial -
Infigratinib 0.016 mg/kg
BridgeBio Oncology Therapeutics
Achondroplasia
1 trial -
Infigratinib is provided as a single dose of minitablets for oral administration
BridgeBio Oncology Therapeutics
Achondroplasia
1 trial -
Infusion of MSC
Lxo Ireland Designated Activity Company
Discordant Immunological Response in HIV Infected Subjects
1 trial -
Infusion of autologous mononuclear bone marrow cells
Lxo Ireland Designated Activity Company
Idiopathic Dilated Cardiomyopathy
1 trial -
Infusion of mesenchymal stem cells from adipose tissue
Lxo Ireland Designated Activity Company
Faecal Incontinence
1 trial -
Inhaled Treprostinil
United Therapeutics Europe Ltd
Sarcoidosis
1 trial -
Inhaled Treprostinil (Tyvaso Nebulizer)
United Therapeutics Europe Ltd
COPD (Chronic Obstructive Pulmonary Disease)
1 trial -
Iniparib
Sanofi Pasteur
Breast Cancer, Metastatic
1 trial -
Injectable suspension of allogeneic adult mesenchymal stem cells
Lxo Ireland Designated Activity Company
Hidradenitis Suppurativa
1 trial -
Injection of IAH0968+Gemcitabine+Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HER2 Gene Mutation
1 trial -
Injection of humanized nerve growth factor (NGF) antibody
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Cancer Pain
1 trial -
Inotuzumab Ozogamicin±Donor Lymphocyte Infusion
The First People's Hospital of Lianyungang
Leukemia, Lymphocytic, Acute
1 trial -
Inotuzumab ozogamicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Lymphocytic Leukemia
1 trial -
Insulin
United Therapeutics Europe Ltd
Multiple Sclerosis, Relapsing-Remitting
1 trial -
Insulin
United Therapeutics Europe Ltd
Acute Stroke
1 trial -
Insulin lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type 1
2 trials -
Insulin lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type II
1 trial -
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
The George Institute
Ovarian Cancer
1 trial -
Interactive injection and sexual risk intervention
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Interferon Beta-1B
The University of Hong Kong
COVID
1 trial -
Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells
The First People's Hospital of Lianyungang
B Cell Lymphoma
1 trial -
Intermittent Oral Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine
1 trial -
Intermittent PD-1/PD-L1 ICI + VEGFR-TKI
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Renal Cell Carcinoma (RCC)
1 trial
Frequently asked questions
How many Phase II pipeline programs are in the directory?
7,238 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.